Top-News

Benitec Biopharma ADR News

Keine aktuellen Kursdaten verfügbar
WKN: A2PVQB
ISIN: US0820534065
Typ: Aktie

Benitec Biopharma ADR News

15.11.21 - PR Newswire
Benitec Biopharma Discloses Q1 2022 Financial Results
Benitec Biopharma Discloses Q1 2022 Financial Results PR Newswire
13.09.21 - PR Newswire
Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference
Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference PR Newswire
08.09.21 - PR Newswire
Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals
Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals PR Newswire
08.09.21 - PR Newswire
Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022
Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022 PR Newswire
27.04.21 - PR Newswire
Benitec Biopharma Increases Previously Announced Bought Deal Offering of Common Stock to $12.9 Million
Benitec Biopharma Increases Previously Announced Bought Deal Offering of Common Stock to $12.9 Million PR Newswire
23.03.21 - PR Newswire
Thinking about buying stock in Sundial Growers, Liquid Media, Benitec Biopharma, Evolve Transition Infrastructure, or Zomedica?
Thinking about buying stock in Sundial Growers, Liquid Media, Benitec Biopharma, Evolve Transition Infrastructure, or Zomedica? PR Newswire
24.02.21 - PR Newswire
Benitec Biopharma Announces Successful Results from the Interim Analysis of the BB-301 Pilot Dosing Study
Benitec Biopharma Announces Successful Results from the Interim Analysis of the BB-301 Pilot Dosing Study PR Newswire
07.12.20 - PR Newswire
Benitec Biopharma Announces 2020 Annual Stockholder Meeting
Benitec Biopharma Announces 2020 Annual Stockholder Meeting PR Newswire
02.10.20 - PR Newswire
Benitec Biopharma Announces Pricing of $10.0 Million Public Offering
Benitec Biopharma Announces Pricing of $10.0 Million Public Offering PR Newswire
23.09.20 - PR Newswire
Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results
Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results PR Newswire
01.09.20 - PR Newswire
Benitec Biopharma to present at H.C. Wainwright's 22nd Annual Global Investment Conference
Benitec Biopharma to present at H.C. Wainwright's 22nd Annual Global Investment Conference PR Newswire
08.07.20 - PR Newswire
Benitec Biopharma Provides Update on BB-301 Tissue Transduction Study
Benitec Biopharma Provides Update on BB-301 Tissue Transduction Study PR Newswire
14.04.20 - PR Newswire
Benitec Biopharma Appoints Edward Smith to the Board of Directors
Benitec Biopharma Appoints Edward Smith to the Board of Directors PR Newswire
26.03.20 - PR Newswire
Benitec Announces Results of Scheme Meeting
Benitec Announces Results of Scheme Meeting PR Newswire
31.01.20 - PR Newswire
Appendix 4C: Quarterly Cash Flow Report
Appendix 4C: Quarterly Cash Flow Report Highlights: -Cash reserves of approximately A$19.6 million -Finalized design of BB-301 tissue transduction study in large animals -...
27.11.19 - PR Newswire
ASX/NASDAQ ANNOUNCEMENT: Re-domiciliation to the United States
ASX/NASDAQ ANNOUNCEMENT: Re-​domiciliation to the United States PR Newswire
31.10.19 - PR Newswire
Appendix 4C: Quarterly Cash Flow Report
Appendix 4C: Quarterly Cash Flow Report Highlights: - Cash reserves of approximately A$24.6 million - Secured A$3.22 million of additional funding through a Registered Direct ...
19.09.19 - PR Newswire
Benitec Biopharma to present at Ladenburg Thalmann 2019 Healthcare Conference
Benitec Biopharma to present at Ladenburg Thalmann 2019 Healthcare Conference PR Newswire
16.09.19 - PR Newswire
Benitec Biopharma Provides Update on BB-301 Oculopharyngeal Muscular Dystrophy (OPMD) Program
Benitec Biopharma Provides Update on BB-301 Oculopharyngeal Muscular Dystrophy (OPMD) Program PR Newswire
31.07.19 - PR Newswire
ASX/NASDAQ ANNOUNCEMENT Appendix 4C: Quarterly Cash Flow Report
ASX/NASDAQ ANNOUNCEMENT Appendix 4C: Quarterly Cash Flow Report PR Newswire

Newssuche

Videos

newspaper
08:40 Uhr +11,66%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »